pharmaceutical companies

5 statements across 5 episodes · 3 bullish · 1 bearish · 5 people on the record · first statement Jan 2, 2019 by Jeff Woo · across every show →

Everything said about pharmaceutical companies, oldest first

Jan 2, 2019 negative
Assertion Not checkable as stated
Wu: Pharma ignores open-domain nootropics due to lack of patent incentives
“So they cannot be patented, therefore there's not a monopolistic sort of end goal for companies to pharmaceuticalize.”
Jeff Woo Jan 2, 2019 ▶ 5:50 a16z Podcast | Nootropics and the Best Version of Your Brain, Yourself
Jan 2, 2019 bullish
Prediction Not checkable as stated
Kindler: Pharma will virtualize and outsource all functions except commercialization
“And in my opinion, the thing they're really good at that I find it hard to imagine being disrupted in the very near future is that translational stage from late stage assets to initial commercialization, figuring out what the market wants. And again, By analog…”
Jeff Kindler Jan 2, 2019 ▶ 19:28 a16z Podcast | Move Fast But Don't Break Things (When It Comes to Computational Biology)
Jan 2, 2019 bullish
Prediction Not checkable as stated
Pandey: Pharma companies will reframe themselves as data science companies
“Pharma companies will start to view themselves more as data generating companies and data science companies.”
Vijay Pande Jan 2, 2019 ▶ 9:06 a16z Podcast | When (and How) Biology Becomes Engineering
Apr 29, 2020 neutral
Insight
Advanced cell and gene therapies require novel pricing and reimbursement models
“If we're gonna make this widely accessible to patients that need them, it's gonna have to be affordable. So we'll need new models for how pharmaceutical companies charge for this, and we're seeing early days of this. We're going to need new models for how paye…”
Jorge Conde Apr 29, 2020 ▶ 18:09 Healthcare Has Left the Building
Aug 1, 2024 positive
Insight
Branson calls human outcome data big pharma's biggest competitive AI advantage
“Outcome data is, is, is the gold standard data to have, right? It's the rarest data that's really, like, one of the advantages of pharmaceutical companies have, because they can generate data in humans at scale in a safe, ethical manner.”
Kim Branson Aug 1, 2024 ▶ 27:56 AI in Pharmaceutical R&D with Kim Branson
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.